September 10, 2025 a 03:31 am

CME: Dividend Analysis - CME Group Inc.

CME Group Inc. Overview

CME Group Inc. exhibits a strong dividend yield with a history of consistent dividend payments. Their commitment to returning value to shareholders is evident in their stable dividend growth and high payout ratios, although these warrant close monitoring in relation to earnings stability.

๐Ÿ“Š Overview

The financial sector presents a robust opportunity through CME Group Inc., distinguished by a dividend yield of 4.09% and an impressive 23-year dividend history.

Feature Details
Sector Financial
Dividend yield 4.09%
Current dividend per share $9.97 USD
Dividend history 23 years
Last cut or suspension None

๐Ÿ“ˆ Dividend History

The company's commitment to consistent dividend payments enhances investor confidence and underscores financial health.

CME Dividend History Chart
Year Dividend per Share (USD)
2025 $3.75
2024 $10.40
2023 $9.65
2022 $8.50
2021 $6.85

๐Ÿ“ˆ Dividend Growth

Tracking dividend growth is essential for investors seeking compounding potential from dividend income.

Time Growth
3 years 14.93%
5 years 13.59%

The average dividend growth is 13.59% over 5 years. This shows moderate but steady dividend growth.

CME Dividend Growth Chart

๐Ÿ“‰ Payout Ratio

The payout ratio is a critical metric, indicating how much of the profits are distributed as dividends, reflecting financial sustainability.

Key Figure Ratio
EPS-based 95.50%
Free cash flow-based 87.50%

The high EPS payout ratio of 95.50% suggests that nearly all profits are returned to shareholders. The FCF ratio of 87.50% underlines a sustainable payout strategy.

๐Ÿ—ฃ๏ธ Cashflow & Capital Efficiency

Assessing cash flow yields and capital efficiency metrics gives insight into operational efficiency and fiscal health.

Metric 2024 2023 2022
Free Cash Flow Yield 4.31% 4.47% 4.92%
Earnings Yield 4.22% 4.27% 4.46%
CAPEX to Operating Cash Flow 2.11% 2.21% 2.94%
Stock-based Compensation to Revenue 1.46% 1.49% 1.68%
Free Cash Flow / Operating Cash Flow Ratio 97.45% 97.79% 97.06%
Return on Invested Capital 8.51% 7.34% 6.37%

The cash flow figures indicate robust operational cash generation with effective capital deployment. The company maintains a healthy cash conversion cycle, reflecting efficiency and flexibility in operations.

โš ๏ธ Balance Sheet & Leverage Analysis

Balance sheet leverage ratios highlight credit risk, liquidity stance, and long-term solvency.

Metric 2024 2023 2022
Debt-to-Equity 12.94% 14.53% 12.86%
Debt-to-Assets 2.49% 2.99% 1.97%
Debt-to-Capital 11.46% 12.68% 11.39%
Net Debt to EBITDA 0.11 0.21 0.18
Current Ratio 1.02 1.02 1.01
Quick Ratio 1.01 1.02 0.03
Financial Leverage 5.19 4.85 6.51

The stability of CME Group Inc.'s balance sheet is illustrated by its low leverage ratios, indicating prudent debt management and strong liquidity positioning.

๐Ÿ—ฏ๏ธ Fundamental Strength & Profitability

Profit metrics and return ratios provide insight into the company's core operational performance and efficiency.

Metric 2024 2023 2022
Return on Equity 13.31% 12.07% 10.06%
Return on Assets 2.57% 2.49% 1.54%
Net Margin 57.52% 57.83% 53.61%
EBIT Margin 76.71% 77.31% 72.78%
EBITDA Margin 82.20% 83.63% 80.01%
Gross Margin 86.13% 85.15% 84.99%
Research & Development to Revenue 0% 0% 0%

With robust ROE and margins, CME Group Inc. demonstrates a strong profitability profile, paving the way for sustainable growth and shareholder returns.

๐Ÿ“‰ Price Development

CME Price Development

๐ŸŒŸ Dividend Scoring System

Category Score Score Bar
Dividend yield 5
Dividend Stability 5
Dividend growth 4
Payout ratio 3
Financial stability 4
Dividend continuity 5
Cashflow Coverage 4
Balance Sheet Quality 4
Total Score: 34/40

โœ… Rating

Based on a comprehensive analysis of CME Group Inc.'s dividend profile, the company's commitment to maintaining robust dividend payments alongside steady growth and financial stability positions it as a strong candidate for income-focused investors. The firm's consistent management of payout ratios amidst strong financial fundamentals supports a favorable investment thesis for long-term holdings.